Viking Therapeutics (VKTX) Competitor Comparison
We are evaluating the key criteria listed to compare Viking Therapeutics (VKTX) against its competitors in the Biotechnology industry.
Market Capitalization
21 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
0 / 337Free Cashflow
184 / 352Quick Ratio
13 / 357Earnings per Share
125 / 359Dividend yield
0 / 6Total Cash
80 / 358Performance 3 years
4 / 368Performance 5 years
16 / 368Performance 10 years
16 / 368Linearity 3 years
356 / 368Linearity 5 years
346 / 368Linearity 10 years
339 / 368Total Rank
60 / 368Dividend Rank
304 / 368Valuation Rank
98 / 368Piotroski Rank
93 / 368Muliplier Rank
233 / 368EBITDA - VKTX ranking 0 / 337
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.